Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Publications

Search Items: HDAC INHIBITOR, . hits: 14

2022

Eaton, DM; Martin, TG; Kasa, M; Djalinac, N; Ljubojevic-Holzer, S; Von, Lewinski, D; Pöttler, M; Kampaengsri, T; Krumphuber, A; Scharer, K; Maechler, H; Zirlik, A; McKinsey, TA; Kirk, JA; Houser, SR; Rainer, PP; Wallner, M HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension.
Pharmaceutics. 2022; 14(7): Doi: 10.3390/pharmaceutics14071509 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moku, G; Vangala, S; Yakati, V; Gali, CC; Saha, S; Madamsetty, VS; Vyas, A Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells
ANTI-CANCER AGENT ME. 2022; 22(5): 914-925. Doi: 10.2174/1871520621666210901102425
Web of Science PubMed FullText FullText_MUG

 

2020

Wallner, M; Eaton, DM; Berretta, RM; Liesinger, L; Schittmayer, M; Gindlhuber, J; Wu, J; Jeong, MY; Lin, YH; Borghetti, G; Baker, ST; Zhao, H; Pfleger, J; Blass, S; Rainer, PP; von Lewinski, D; Bugger, H; Mohsin, S; Graier, WF; Zirlik, A; McKinsey, TA; Birner-Gruenberger, R; Wolfson, MR; Houser, SR HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.
Sci Transl Med. 2020; 12(525): Doi: 10.1126/scitranslmed.aay7205 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Hofving, T; Arvidsson, Y; Almobarak, B; Inge, L; Pfragner, R; Persson, M; Stenman, G; Kristiansson, E; Johanson, V; Nilsson, O The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
ENDOCR-RELAT CANCER. 2018; 25(3): 367-380. Doi: 10.1530/ERC-17-0445 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Partolina, M; Thoms, HC; MacLeod, KG; Rodriguez-Blanco, G; Clarke, MN; Venkatasubramani, AV; Beesoo, R; Larionov, V; Neergheen-Bhujun, VS; Serrels, B; Kimura, H; Carragher, NO; Kagansky, A Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.
Cell Death Discov. 2017; 3: 16077 Doi: 10.1038/cddiscovery.2016.77 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ritter, C; Fan, K; Paschen, A; Reker Hardrup, S; Ferrone, S; Nghiem, P; Ugurel, S; Schrama, D; Becker, JC Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
Sci Rep. 2017; 7(1):2290-2290 Doi: 10.1038/s41598-017-02608-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Arvidsson, Y; Johanson, V; Pfragner, R; Wängberg, B; Nilsson, O Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells.
Neuroendocrinology. 2016; 103(5):578-591 Doi: 10.1159/000441849
Web of Science PubMed FullText FullText_MUG

 

He, JC; Yao, W; Wang, JM; Schemmer, P; Yang, Y; Liu, Y; Qian, YW; Qi, WP; Zhang, J; Shen, Q; Yang, T TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
Oncotarget. 2016; 7(46):75441-75456 Doi: 10.18632/oncotarget.12254 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Mol Cancer. 2015; 14(8):4-4 Doi: 10.1186/1476-4598-14-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Fröhlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Zatloukal, K Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells.
PLoS One. 2014; 9(3):e91558-e91558 Doi: 10.1371/journal.pone.0091558 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Scheipl, S; Lohberger, B; Rinner, B; Froehlich, EV; Beham, A; Quehenberger, F; Lazáry, A; Pal Varga, P; Haybaeck, J; Leithner, A; Liegl, B Histone deacetylase inhibitors as potential therapeutic approaches for chordoma: an immunohistochemical and functional analysis.
J Orthop Res. 2013; 31(12):1999-2005 Doi: 10.1002/jor.22447 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Shirsath, N; Rathos, M; Chaudhari, U; Sivaramakrishnan, H; Joshi, K Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Lung Cancer. 2013; 82(2):214-221 Doi: 10.1016/j.lungcan.2013.08.010
Web of Science PubMed FullText FullText_MUG

 

2009

Fröhlich, E; Brossart, P; Wahl, R Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Eur J Nucl Med Mol Imaging. 2009; 36(5):780-790 Doi: 10.1007/s00259-008-1024-6
Web of Science PubMed FullText FullText_MUG

 

2006

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Staber, PB; Zatloukal, K; Denk, H Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
Mol Cancer Ther. 2006; 5(9):2203-2210 Doi: 10.1158/1535-7163.MCT-05-0480 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint